336 related articles for article (PubMed ID: 8456325)
1. Recombinant blood clotting proteins for hemophilia therapy.
Limentani SA; Roth DA; Furie BC; Furie B
Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325
[No Abstract] [Full Text] [Related]
2. Surgery in haemophilic patients with inhibitors.
Rodriguez-Merchan EC
Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
[No Abstract] [Full Text] [Related]
3. [Advances in the field of hemophilia therapy].
Loeliger EA; Veltkamp JJ
Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135
[No Abstract] [Full Text] [Related]
4. Hemophiliacs with inhibitors: therapeutic options.
Roberts HR
N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
[No Abstract] [Full Text] [Related]
5. [Acquired hemophilia: current status in Japan and immuno-biochemical features of autoantibodies to factor VIII].
Tanaka I; Shima N
Rinsho Ketsueki; 2005 Feb; 46(2):91-8. PubMed ID: 16447701
[No Abstract] [Full Text] [Related]
6. Editorial: Factor VIII inhibitors.
Deykin D
N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
[No Abstract] [Full Text] [Related]
7. Recombinant antihemophilic factors.
Kurachi K
Biotechnology; 1991; 19():177-95. PubMed ID: 1786471
[No Abstract] [Full Text] [Related]
8. [Coagulation factors. Indications and applications].
Stampfli K; Hartmann S
Ther Umsch; 1984 Aug; 41(8):571-5. PubMed ID: 6437000
[No Abstract] [Full Text] [Related]
9. Recombinant clotting factor concentrates.
Lusher JM
Baillieres Clin Haematol; 1996 Jun; 9(2):291-303. PubMed ID: 8800506
[No Abstract] [Full Text] [Related]
10. Hemophilia.
Aledort LM
N Engl J Med; 2001 Oct; 345(14):1066; author reply 1067. PubMed ID: 11586968
[No Abstract] [Full Text] [Related]
11. Induced immunotolerance in factor VIII inhibitor patients.
Brackmann HH
Prog Clin Biol Res; 1984; 150():181-95. PubMed ID: 6431426
[No Abstract] [Full Text] [Related]
12. Molecular biology of coagulation.
Pavirani A; Bischoff R
Schweiz Med Wochenschr Suppl; 1991; 43():55-7. PubMed ID: 1843038
[No Abstract] [Full Text] [Related]
13. Treatment of hemophilia B with a new clotting-factor concentrate.
Hoag MS; Johnson FF; Robinson JA; Aggeler PM
N Engl J Med; 1969 Mar; 280(11):581-6. PubMed ID: 5764825
[No Abstract] [Full Text] [Related]
14. [Treatment of hemophiliacs with inhibitors].
Fujimaki M
Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
[No Abstract] [Full Text] [Related]
15. Pioneering designs for recombinant coagulation factors.
Schulte S
Thromb Res; 2011; 128 Suppl 1():S9-12. PubMed ID: 22221848
[TBL] [Abstract][Full Text] [Related]
16. The promise and challenges of bioengineered recombinant clotting factors.
Pipe SW
J Thromb Haemost; 2005 Aug; 3(8):1692-701. PubMed ID: 16102035
[TBL] [Abstract][Full Text] [Related]
17. [Blood plasma fractions for the management of coagulation disorders: 3. The P.P.S.B. fraction].
Richter K; Klingenberg K; Reinecke D
Z Gesamte Inn Med; 1968 Jan; 23(1):18-21. PubMed ID: 5662427
[No Abstract] [Full Text] [Related]
18. Recent advances in the development of coagulation factors and procoagulants for the treatment of hemophilia.
Schaub RG
Biochem Pharmacol; 2011 Jul; 82(2):91-8. PubMed ID: 21453683
[TBL] [Abstract][Full Text] [Related]
19. [6-years' experience with the clinical use of the hemostatic preparation, PPSB].
Koniukhov SG; Saltykova ZA; Tarasova LN
Probl Gematol Pereliv Krovi; 1977 Aug; 22(8):37-40. PubMed ID: 928338
[No Abstract] [Full Text] [Related]
20. [Clinical experience with the PPSB fraction in surgery].
Frick U
Zentralbl Chir; 1972 Feb; 97(5):150-3. PubMed ID: 5020589
[No Abstract] [Full Text] [Related]
[Next] [New Search]
